Patients with type 2 diabetes secrete not only too little insulin but also too much glucagon, which contributes to poor blood glucose control. A new study from Uppsala University suggests that this is ...

An innovative ‘smart insulin’ may offer people living with type 1 diabetes improved treatment options to regulate blood glucose levels. This is the discovery of researchers at Indiana University, who ...

For the first time, humans with newly diagnosed Type 1 diabetes, or T1D, have received two treatments called GABA and GAD that have shown promise in animal studies and in isolated human pancreas ...

Novel Glucagon like peptide-1 (GLP-1) drugs were designed and industrial prepared by researchers from Hefei Institutes of Physical Science, Chinese Academy of Sciences Through molecular design, strain ...

CHICAGO & DUBLIN--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ...

By Dr. Priyom Bose, Ph.D. A 26-week trial reveals that metformin, long viewed as a promising add-on therapy, lowers insulin ...

New clinical trial results revealed that orforglipron could become the first GLP-1 weight-loss drug accessible as a pill rather than an injection.The daily oral drug, developed by Danish ...

CHICAGO & DUBLIN--(BUSINESS WIRE)-- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ...